Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonadonna, R. C.
Right arrow Articles by van Haeften, T. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonadonna, R. C.
Right arrow Articles by van Haeften, T. W.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 52:470-480, 2003
© 2003 by the American Diabetes Association, Inc.

Altered Homeostatic Adaptation of First- and Second-Phase ß-Cell Secretion in the Offspring of Patients With Type 2 Diabetes

Studies With a Minimal Model to Assess ß-Cell Function

Riccardo C. Bonadonna1, Michael Stumvoll2, Andreas Fritsche2, Michele Muggeo1, Hans Häring2, Enzo Bonora1, and Timon W. van Haeften3

1 Division of Endocrinology and Metabolic Diseases, University of Verona and Azienda Ospedaliera di Verona, Verona, Italy
2 Medizinische Klinik, Abteilung für Endokrinologie, Stoffwechsel und Pathobiochemie, Eberhard-Karls-Universität, Tübingen, Germany
3 Department of Internal Medicine, University Medical Center, Utrecht, the Netherlands

We adapted a minimal model to assess ß-cell function during a hyperglycemic glucose clamp and to uncover peculiar aspects of the relationship among ß-cell function, plasma glucose, and insulin sensitivity (IS) in offspring of Caucasian patients with type 2 diabetes (OfT2D). We pooled two data sets of OfT2D (n = 69) and control subjects (n = 45) with normal glucose regulation. Plasma C-peptide was measured during a hyperglycemic clamp (~10 mmol/l) to quantify model-based first-phase secretion and glucose sensitivity of second-phase secretion (ß). IS was quantified during the hyperglycemic clamp. In the pooled data, first-phase secretion was linearly and negatively related to fasting plasma glucose, but not IS; OfT2D lay on a distinct line shifted to the left of the control subjects. In contrast, ß was negatively related to IS, and OfT2D lay on a distinct line shifted more and more to the left of the control subjects, as IS was worse. Thus, in OfT2D lower ß-cell adaptive responses exist between ambient glycemia and first-phase insulin secretion and between IS and second-phase secretion. Under conditions leading to decreased insulin sensitivity, these disturbed relationships may lead to progression to diabetes in OfT2D.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
R. Weiss, S. Caprio, M. Trombetta, S. E. Taksali, W. V. Tamborlane, and R. Bonadonna
{beta}-Cell Function Across the Spectrum of Glucose Tolerance in Obese Youth
Diabetes, June 1, 2005; 54(6): 1735 - 1743.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Mari, A. Gastaldelli, A. Natali, T. Ostergard, O. Schmitz, and E. Ferrannini
Characterization of {beta}-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests
Am J Physiol Endocrinol Metab, March 1, 2005; 288(3): E541 - E546.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. A. Arslanian, F. Bacha, R. Saad, and N. Gungor
Family History of Type 2 Diabetes Is Associated With Decreased Insulin Sensitivity and an Impaired Balance Between Insulin Sensitivity and Insulin Secretion in White Youth
Diabetes Care, January 1, 2005; 28(1): 115 - 119.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
B. Ahren, R. Gomis, E. Standl, D. Mills, and A. Schweizer
Twelve- and 52-Week Efficacy of the Dipeptidyl Peptidase IV Inhibitor LAF237 in Metformin-Treated Patients With Type 2 Diabetes
Diabetes Care, December 1, 2004; 27(12): 2874 - 2880.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Caumo and L. Luzi
First-phase insulin secretion: does it exist in real life? Considerations on shape and function
Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E371 - E385.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. Bonora, S. Kiechl, J. Willeit, F. Oberhollenzer, G. Egger, J. B. Meigs, R. C. Bonadonna, and M. Muggeo
Population-Based Incidence Rates and Risk Factors for Type 2 Diabetes in White Individuals: The Bruneck Study
Diabetes, July 1, 2004; 53(7): 1782 - 1789.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. Thamer, M. Stumvoll, A. Niess, O. Tschritter, M. Haap, R. Becker, F. Shirkavand, O. Bachmann, K. Rett, A. Volk, et al.
Reduced Skeletal Muscle Oxygen Uptake and Reduced {beta}-Cell Function: Two early abnormalities in normal glucose-tolerant offspring of patients with type 2 diabetes
Diabetes Care, July 1, 2003; 26(7): 2126 - 2132.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.